Literature DB >> 164462

Analysis of the requirements for parathyroid hormone action in renal membranes with the use of inhibiting analogues.

D Goltzman, D Goltzmann, A Peytremann, E Callahan, G W Tregear, J T Potts.   

Abstract

Two synthetic analogues of bovine parathyroid hormone (PTH) with NH2-terminal modifications, PTH-(3-34) and [desamino-Ala-1]PTH-(1-34), were found to lack agonist activity but to demonstrate antagonist properties when tested in the rat renal cortical adenylyl cyclase assay in vitro against the native hormone or against PTH-(1-34), the active synthetic NH2-terminal tetratriacontapeptide. The inhibition exhibited by these analogues was proportional in degree to the dose of inhibitor, abolished by oxidation of the analogue, reversible by addition of an excess of active hormone, and specific for parathyroid hormone-stimulated renal adenylyl cyclase. No inhibition of basal or sodium fluoride-stimulated renal adenylyl cyclase could be demonstrated. Two other synthetic bovine analogues, PTH-(13-34) and PTH-(1-26), were devoid of agonist and antagonist properties. The over-all results suggest that the requirements for receptor binding of parathyroid hormone are rather broad. Conformational factors or binding interactions involving specific residues, or both seem to require the entire sequence from residue 3 to residue 27 for receptor binding to occur. A dichotomy between receptor binding and adenylyl cyclase activation was demonstrated only by alterations or deletions involving the first 2 NH2-terminal residues of the hormone and emphasizes the importance of these residues in eliciting the biological activity of parathyroid hormone. The two antagonists, [desamino-Ala-1]PTH-(1-34) and PTH-(3-34), should be useful in further analysis of the initial steps in hormone action.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164462

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Interaction of PTH and PTHrP with their receptors.

Authors:  T J Gardella; H Jüppner
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Metabolism and biological activity of parathyroid hormone in renal cortical membranes.

Authors:  D Goltzman; A Peytremann; E N Callahan; G V Segre; J T Potts
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

3.  The history of parathyroid hormone and its receptor: structure-based design of parathyroid hormone analogues.

Authors:  J T Potts; T J Gardella; H Jüppner; H Kronenberg
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Relative sensitivity of kidney and bone to the amino-terminal fragment b-PTH (1-30) of native bovine parathyroid hormone: implications for assessment of bioactivity of parathyroid hormone fragments in vivo and in vitro.

Authors:  K J Martin; E Bellorin-Font; J J Morrissey; R L Jilka; R R MacGregor; D V Cohn
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

5.  Action of bPTH and bPTH fragments on embryonic bone in vitro: dissociation of the cyclic AMP and bone resorbing response.

Authors:  M P Herrmann-Erlee; P J Nijweide; J M van der Meer; M A Ooms
Journal:  Calcif Tissue Int       Date:  1983       Impact factor: 4.333

6.  Effect of ACTH on PTH-stimulated bone resorption in vitro.

Authors:  J H Dominguez; L G Raisz
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

7.  Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.

Authors:  D Goltzman; A S Tischler
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

8.  Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy.

Authors:  A F Stewart; K L Insogna; D Goltzman; A E Broadus
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

9.  Inhibition of the in vivo parathyroid hormone-mediated calcemic response in rats by a synthetic hormone antagonist.

Authors:  S H Doppelt; R M Neer; S R Nussbaum; P Federico; J T Potts; M Rosenblatt
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

10.  Isolation and analysis of human parathyrin in parathyroid tissue and plasma. Use of reversed-phase liquid chromatography.

Authors:  H P Bennett; S Solomon; D Goltzman
Journal:  Biochem J       Date:  1981-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.